|
AAAP REVIEW COURSE IN ADDICTION PSYCHIATRY JANUARY 18-19, 2003 HYATT REGENCY DOWNTOWN DENVER
Pre-Conference Buprenorphine Training Friday, January 17
GENERAL INFORMATION Who Should Attend? The AAAP Review Course in Addiction Psychiatry will continue to meet the high academic and scientific standards set by AAAP over the past decade. The course is excellent preparation for the ABPN examinations for subspecialty certification and recertification in addiction psychiatry. Past participants have recommended that this be required for PGY-V residents, for general psychiatry residents, as well as periodically for all academic and treatment personnel to stay updated on the most recent trends in the addiction field. They have found the course to be an excellent way to "piece seemingly disparate aspects together," and "an eye-opener!" It is equally relevant to junior faculty and clinicians as well as experienced practitioners.
Course Site & Accommodations The 2003 Review Course in Addiction Psychiatry will take place at the Hyatt Regency Downtown in Denver, Colorado. Located in the heart of Downtown Denver’s financial and retail districts, the Hyatt Regency Denver is steps from the city’s finest attractions. Guests will find unique shops, galleries and restaurants along the 16 th Street Mall, Denver Pavilions, Larimer Square and Lower Downtown ("LoDo") and can take in the sites which include: Six Flags Elitch Gardens Amusement Park, Coors Field, Pepsi Center, Mile High Stadium, Ocean Journey, Denver Art Museum, Denver Center for the Performing Arts, the U.S. Mint and the State Capitol, all of which are close by or within walking distance.
The deadline for reservations is December 20, 2002.
Reservations will be accepted on a space-available basis only after that date. Hotel reservations can be made using the number listed below. Make sure to mention that you are with the AAAP meeting to receive the special conference room rate. Check-in is 3 p.m., and check-out is noon. AAAP has no control over late check-out times. You must directly request a late check-out time from the hotel. Room Rate: $109 Single or Double
Hyatt Regency Downtown Denver 1750 Welton Street Denver, CO 80202 Reservations Phone: 800-233-1234 or 303-295-1234 Fax: 303-292-2472
Air Travel and Ground Transportation For information on air travel or car rental, contact Passport Incentives+Meetings, the official travel agency for the AAAP Review Course. Passport Incentives offers discounted airfares on select airlines. Please call 800-417-2902 and ask for the AAAP Travel Desk. Super Shuttle offers a discounted price of $30 for a round trip between Denver International Airport and the Hyatt Regency Downtown Denver. Be sure to mention that you are with AAAP to receive this special rate. The Super Shuttle ticket counter is located by the Baggage Claim Level 5 of the Jeppesen Terminal. Call 303-370-1300 for more information.
About the ABPN Exam for Subspecialty Certification in Addiction Psychiatry According to the latest information from the American Board of Psychiatry and Neurology, the recertification examination for the addiction psychiatry subspecialty will be offered March 20, 2003. The application deadline is October 1, 2002 and the late application deadline is November 1, 2002. The next certification exam will take place April 13, 2004. The application deadline is September 1, 2003 and the late application deadline is October 1, 2003.
For more information or to register for the exam, contact the American Board of Psychiatry and Neurology, 500 Lake Cook Road, Suite 335, Deerfield, Illinois 60015. Phone: 847-945-7900, Fax: 847-945-1146, Web site: www.abpn.com.
Course Materials The registration fee includes a syllabus that contains slides with accompanying text, bibliographical information and sample questions. Supplemental materials including books and tape and compact disc recordings of the faculty are available for purchase from AAAP. Materials are available through the AAAP Web Store, www.aaap.org/webstore.htm, and will also be available at the Review Course for purchase at a discounted rate.
AAAP has several books available, including books from the new series, Key Readings in Addiction Psychiatry. The AAAP Web Store contains more than 20 addiction psychiatry-related books, including basic texts that are recommended as supplemental materials to prepare for the examination: Textbook of Substance Abuse Treatment, Second Edition by Galanter and Kleber; Clinical Textbook of Addictive Disorders, Second Edition by Frances and Miller; and Substance Abuse: A Comprehensive Textbook, Third Edition by Lowinson, Ruiz, Millman and Langrod.
Pre-Conference Buprenorphine Training 8 a.m.-5:35 p.m. Friday, January 17
AAAP is one of five organizations designated by the U.S. Department of Health and Human Services (DHHS) to provide such training for physicians to dispense buprenorphine in office practice for treatment of opioid dependence. AAAP Buprenorphine Training Sessions meet the eight hour requirement. Participation in training will provide physicians with a comprehensive overview of buprenorphine prescribing and its safe and effective use in an office-based setting.
Who Should Attend? This training is designed for physicians who are likely to treat opiate-dependent persons in their practice, such as those in family practice, general internal medicine, psychiatry, pediatrics and adolescent medicine specialists. This training would be most valuable for:
Course Schedule 7-8 a.m. Registration & Continental Breakfast 8-8:15 a.m. Welcome and Introductions Elinore F. McCance-Katz, MD, PhD 8:15-8:45 a.m. Overview of the Course, Legislation, Epidemiology Elinore F. McCance-Katz, MD, PhD 8:45-9:30 a.m. Methadone, LAAM, Naltrexone Treatment of Opioid Dependence Elinore F. McCance-Katz, MD, PhD 9:30-10 a.m. Opioid Pharmacology John T. Pichot, MD 10-10:10 a.m. Break 10:10-11 a.m. Buprenorphine Pharmacology John T. Pichot, MD 11-11:45 a.m. Induction, Maintenance, Withdrawal with Buprenorphine Laura F. McNicholas, MD, PhD 11:45 a.m.-12:15 p.m. Small Group Case Discussions 12:15-1:30 p.m. Lunch (On Your Own) 1:30-2:15 p.m. Patient Assessment and Selection and Office Management Laura F. McNicholas, MD, PhD 2:15-3 p.m. Confidentiality and Recordkeeping Elinore F. McCance-Katz, MD, PhD 3-3:10 p.m. Break 3:10-4 p.m. Medical Comorbidity Michael F. Weaver, MD 4-4:45 p.m. Special Treatment Populations Michael F. Weaver, MD 4:45-5:15 p.m. Small Group Case Discussions 5:15-5:35 p.m. Wrap-up and Evaluation Elinore F. McCance-Katz, MD, PhD
Faculty Elinore F. McCance-Katz, MD, PhD, Medical College of Virginia, Virginia Commonwealth University Laura F. McNicholas, MD, PhD, University of Pennsylvania, Philadelphia VAMC John T. Pichot, MD, University of Texas Health Science Center at San Antonio, South Texas Veterans Health Care System Michael F. Weaver, MD, Medical College of Virginia, Virginia Commonwealth University
Registration Fees Separate registration is required. If you are also attending the Review Course: $75 for AAAP members $125 for non-membersIf you are not attending the Review Course: $125 for AAAP members $175 for non-members
Review Course Schedule
Saturday, January 18 7-8 a.m. Registration and Continental Breakfast 8-8:10 a.m. Introduction and Overview Jane Kennedy, DO; University of Colorado School of Medicine 8:10-8:45 a.m. General Concepts of Substance Abuse and Dependence Jane Kennedy, DO; University of Colorado School of Medicine A discussion of general concepts, including DSM criteria, epidemiology and general assessment of substance use problems. 8:45-9:45 a.m. Etiology of Substance Use Disorders Wilson M. Compton II, MD, National Institute on Drug Abuse A biobehavioral approach to the understanding of the etiology of substance use disorders drawing upon current concepts derived from behavior genetics, developmental psychology and cognitive neuroscience. 9:45-10 a.m. Break 10-11 a.m. Alcohol Bryon
Adinoff, MD; University of Texas Southwestern Medical Center, VA North Texas A review of models of alcoholism, genetic contributions, neurobiology, physical and laboratory assessment, medical complications of acute and chronic use, medical management of withdrawal syndromes and pharmacologic and psychosocial treatments for alcoholism. 11 a.m.-Noon. Sedative/Hypnotics Robert Malcolm, Jr., MD; Medical University of South Carolina Presentation on historical aspects of sedatives, biological mechanisms of anxiety, intoxication effects, medical complications of withdrawal, management of detoxification and appropriate use of sedatives/hypnotics in psychiatry. Noon-1:15 p.m. Lunch (On Your Own) 1:15-2:15 p.m. Stimulants Steven Batki, MD; SUNY-Upstate Medical University Information on stimulant use, effects on neurotransmitters, mechanisms in abuse/dependence, intoxication and withdrawal, medical and psychiatric complications and current pharmacologic and psychological approaches to treatment. 2:15-3:15 p.m. Nicotine and Caffeine John Hughes, MD; University of Vermont Thorough discussion of epidemiological considerations such as prevalence, initiation of use, patterns of cessation and antecedents to use; pharmacological and neurobiological mechanisms, psychiatric comorbidity and pharmacological/psychological treatments. 3:15-3:30 p.m. Break 3:30-4:30 p.m. Marijuana, Hallucinogens and PCP John T. Pichot, MD; University of Texas Health Science Center, San Antonio A description of the neurobiology, endogenous receptors and ligands, physiologic and behavioral effects, street names and drug testing of these groups of drugs, as well as review of medical uses of marijuana. 4:30-4:45 p.m. Questions and Answers 4:45-5 p.m. Guide to the Exam Some guidance on specific areas to study, past experiences with the exam and other anxiety-reducing tips.
Sunday, January 19 7-8 a.m. Continental Breakfast 8-9 a.m. Opioids Jane Kennedy, DO; University of Colorado School of Medicine Information on the pharmacology and neurobiology of endogenous and exogenous opioids, physiological effects, treatment of overdose and withdrawal, medical complications and pharmacological treatment of detoxification and maintenance, including methadone, LAAM and buprenorphine. 9-10 a.m. Psychotherapy and Psychosocial Treatments Samuel Ball, PhD, Yale University School of Medicine Comparison of psychotherapeutic and pharmacologic treatments, combined treatment approaches and models of psychosocial treatments including motivational models, 12-step oriented models, cognitive-behavioral therapy, behavioral therapy, psychodynamic therapy and family and marital therapies. 10-10:30 a.m. Break and Check-Out of Hotel 10:30-11:30 a.m. Dual Diagnosis John Talmadge, MD, University of Texas Southwestern Medical School Epidemiological considerations, evaluation and differential diagnosis, distinguishing "primary vs. secondary" comorbid conditions, treatment issues including need for hospitalization, treatment priority of issues (psychiatric vs. substance abuse) and specialized approaches in the treatment of substance abuse in patients with major mental illness.11:30 a.m.-12:30 p.m. Adolescent Substance Abuse Ramon Solhkhah, MD, St. Luke’s-Roosevelt Hospital Center Initiation and prevalence of substance use in adolescents, special psychosocial and developmental issues in adolescents; comorbid psychiatric conditions such as conduct disorder, mood disorders, PTSD and ADHD; and review of treatment modalities such as cognitive-behavioral, family therapy and multi-systemic therapy.12:30-1 p.m. Wrap-Up and Adjourn
Continuing Medical Education Information
Jointly sponsored by The Medical University of South Carolina and The American Academy of Addiction Psychiatry
Review Course Chairs Jane Kennedy, DO; University of Colorado School of Medicine Bryon
Adinoff, MD; University of Texas Southwestern Medical Center, VA North Texas
Review Course Learning Objectives Upon completion of the Review Course, participants should be able to:
Buprenorphine Course Director Elinore F. McCance-Katz, MD, PhD; Medical College of Virginia, Virginia Commonwealth University
Optional Pre-Conference Buprenorphine Training Learning Objectives
Credit Designation The Medical University of South Carolina designates this educational activity for a maximum of 19.75 hours in Category 1 credit towards the AMA Physician’s Recognition Award (8 hours for the Optional Pre-Conference Buprenorphine Training and 11.75 hours for the Review Course). Each physician should claim only those hours of credit that he/she actually spent in the educational activity.
Accreditation Statement This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the Medical University of South Carolina and the American Academy of Addiction Psychiatry. The Medical University of South Carolina is accredited by the ACCME to provide continuing medical education for physicians.
Disclosure of Financial Relationships The Medical University of South Carolina adheres to the Accreditation Council for Continuing Medical Education requirements on disclosure. Information about relationships of presenters with commercial interests will be included in material distributed at the time of the conference.
Disclosure of Discussion of Non-FDA Approved Uses for Pharmaceutical Products and/or Medical Devices As an ACCME accredited provider of continuing medical education, the Medical University of South Carolina requires that all faculty presenters identify and disclose any "off label" uses for pharmaceutical and medical device products.
|